University of Thessaly (UTH)
Κατάσταση θρέψης και αντικειμενική αξιολόγηση της λειτουργικής κατάστασης σε ασθενείς με μεταστατικά νεοπλασματικά νοσήματα που λαμβάνουν συστηματική χημειοθεραπεία
Abstract
dc:descriptionIntroduction: The nutritional status of people with cancer is often adversely affected due to several reasons and the syndrome of cancer cachexia appears frequently in this setting, especially in those with advanced disease. The syndrome is characterized by a continuous loss of muscle mass leading to a progressive functional impairment. Physician-reported subjective assessment of performance status is the established method for the stratification of cancer patients for treatment decisions. Objective measurements of physical function may ameliorate the predictive and prognostic value of functionality in this setting. Furthermore, the application of the recently published criteria for the diagnosis of cachexia, sarcopenia and malnutrition syndromes may provide more information on the predictive and prognostic value of these syndromes towards patients’ outcomes. The aim of this PhD thesis was to thoroughly assess the nutritional status as well as the physical function through objective methods in a sample of people with metastatic cancer disease, to explore: (a) the predictive and prognostic value of 5 different objective tools assessing physical function; (b) the prevalence of cachexia, sarcopenia and malnutrition, using the recently published international diagnostic criteria and their predictive and prognostic value towards patients’ outcomes. Methodology: Demographic characteristics, data on medical history and present disease, as well as biochemical indices, were collected from medical records at baseline evaluation at the time of diagnosis. Low performance status was assessed at diagnosis using the subjective Eastern Cooperative Oncology Group Performance Status (ECOG-PS), as well as the following objective physical function assessment tools: Handgrip Strength [(HGS) <27kg for males, <16kg for females], Chair Stand Test [(CST) >15 sec], Timed Up and Go [(TUG) test, >20 sec], 4m Gait Speed [(GS) <0.8 m/sec] and the Short Physical Performance Battery [(SPPB) test, < 8 score]. The nutritional status of the volunteers was evaluated by applying, the International Consensus Definition Criteria (ICDC) for the diagnosis of cancer cachexia, the revised criteria for the diagnosis of sarcopenia from the European Working Group on Sarcopenia in Older People 2 (EWGSOP2)] and the Global Leadership Initiative on Malnutrition (GLIM) criteria for the diagnosis of malnutrition. Cachexia was diagnosed with unintentional weight loss >5% in the past 6 months or with a body mass index (BMI) <20 kg/m2 and any degree of weight loss >2% or with any degree of weight loss >2% and low muscle mass assessed by the skeletal muscle index [(SMI) <55 cm²/m² for men, <39 cm²/m2 for women] which was determined by CT image analysis at the 3rd lumbar vertebra. Handgrip strength (HGS) was used to assess muscle strength. Sarcopenia was defined as low muscle strength combined with low muscle mass. Weight loss and BMI were used for the assessment of malnutrition, as well as SMI for the assessment of low muscle mass. Decreased food intake/absorption was assessed using the Edmonton Symptom Assessment Scale (ESAS) and the Mini Nutritional Assessment (MNA). C-reactive protein was used as a laboratory marker of systemic inflammation. Patients were re-evaluated at 3 months follow up and data were prospectively collected from medical records regarding disease progression and overall survival (OS) up to May 2020. Results: The study included 103 volunteers with metastatic cancer [upper gastrointestinal tract (36.9%), lung (24.3%), lower gastrointestinal tract (21.4%)], with a median age of 74.0 (68, 81) years, (68.9% men). Subjects with poor performance status according to the ECOG-PS (Hazard Ratio [HR]: 3.80, 95% Confidence Interval (CI): 1.84, 7.80), low HGS (HR: 2.37, 95% CI: 1.24, 4.55), low SPPB score (HR: 3.43, 95% CI: 1.55, 7.57), low GS (HR: 3.03, 95% CI: 1.44, 6. 38), and long TUG (HR: 5.16, 95% CI: 2.19, 12.14) had lower OS after adjusting for sex, age, symptomatology, comorbidity, %weight loss, and tumor localisation. In addition, in a subset of 56 volunteers for whom CT scans were available, 76.8% (n=43) of patients were diagnosed with cachexia, 35.7% (n=20) with sarcopenia, and 89.3% (n=50) with malnutrition. In multivariate analysis, after adjustment for age, sex and tumor localization, the presence of cachexia and sarcopenia were independently associated with a 3-fold increased risk of death (HR: 3.00 95% CI 1.08-8.34, p = 0.036), (HR 2.98 95% CI 1.27-6.99, p = 0.011), respectively. Conclusions: Reduced physical function evaluated by subjective and objective assessment tools at the diagnosis of the disease, was associated with an increased risk of death. Similarly, the presence of cachexia and sarcopenia, diagnosed by the international diagnostic criteria, were associated with lower overall survival.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Migdanis, Ioannis
- Μιγδάνης, Ιωάννης
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56299